ADXS-503 for Metastatic Squamous and NSCLC - Clinical Trial
What is the Purpose of this Study?
We are doing this study to learn if the study drugs (ADXS-503 and Pembrolizumab) are safe to give, and whether they are useful therapies for non-small cell lung cancer.
Non Small Cell Lung Cancer (NSCLC)
Who Can Participate in the Study?
Adults 18 and older with NSCLC
What is Involved?
If you choose to join this study, you will:
-Be in the study for up to 24 months
-Get chemotherapy and immunotherapy
-Give blood samples
-Possibly give a small sample of lung tissue
-Complete regular care with your doctor